SynthesisNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2023

Dimethyl Fumarate or Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing Studies.

Luca Prosperini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.